Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8.
Thomas WalleJoscha A KraskeBoyu LiaoBénédicte LenoirCarmen TimkeEmilia von Bohlen Und HalbachFlorian TranPaul GriebelDorothee AlbrechtAzaz AhmedMeggy Suarez-CarmonaAlejandro Jiménez-SánchezTizian BeikertAlexandra Tietz-DahlfußAyse Nur MenevseGabriele SchmidtManuela BromJens H W PahlWiebke AntonopoulosMatthias MillerRamon Lopez PerezFelix BestvaterNathalia A GiesePhilipp BeckhovePhilip C RosenstielDirk JägerOliver StrobelDana Pe'erNiels HalamaJuergen DebusAdelheid CerwenkaPeter E HuberPublished in: Science advances (2022)
Radiotherapy is a mainstay cancer therapy whose antitumor effects partially depend on T cell responses. However, the role of Natural Killer (NK) cells in radiotherapy remains unclear. Here, using a reverse translational approach, we show a central role of NK cells in the radiation-induced immune response involving a CXCL8/IL-8-dependent mechanism. In a randomized controlled pancreatic cancer trial, CXCL8 increased under radiotherapy, and NK cell positively correlated with prolonged overall survival. Accordingly, NK cells preferentially infiltrated irradiated pancreatic tumors and exhibited CD56 dim -like cytotoxic transcriptomic states. In experimental models, NF-κB and mTOR orchestrated radiation-induced CXCL8 secretion from tumor cells with senescence features causing directional migration of CD56 dim NK cells, thus linking senescence-associated CXCL8 release to innate immune surveillance of human tumors. Moreover, combined high-dose radiotherapy and adoptive NK cell transfer improved tumor control over monotherapies in xenografted mice, suggesting NK cells combined with radiotherapy as a rational cancer treatment strategy.
Keyphrases
- nk cells
- radiation induced
- radiation therapy
- immune response
- early stage
- endothelial cells
- locally advanced
- high dose
- cancer therapy
- clinical trial
- public health
- single cell
- innate immune
- stem cells
- low dose
- drug delivery
- dna damage
- oxidative stress
- dendritic cells
- study protocol
- cell proliferation
- skeletal muscle
- mesenchymal stem cells
- open label
- stem cell transplantation
- free survival
- phase ii